ESMO 2025 Spotlight On: ESMO 2025 collates pharmaphorum's coverage of the Congress, including expert insights and interviews.

#ESMO #EuropeanSocietyforMedicalOncology #ESMO2025 #cancerprevention #cancerscreening #earlydiagnosisofcancer #oncologybreakthroughs #translationalcancerresearch #clinicalcancerresearch #cancertreatments #futureofcancercare #Cancerdrugresearch #integratedcancercare
zurl.co/pPv0n

🎓 Thrilled to join again this year as faculty at #MCCR25, working with dedicated young researchers and alongside some of the leading experts in oncology.

Grateful to bring the patient voice into this unique and intense clinical research setting🤩

#MCCR25 #ClinicalCancerResearch @eortc.org

Mayo Clinic Researchers Identify Proteins Linked to Immunotherapy Resistance in Metastatic Colorectal Cancer | Newswise A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with metastatic colorectal cancer. In findings published in Clinical Cancer Research, th...

Mayo Clinic Researchers Identify Proteins Linked to Immunotherapy Resistance in Metastatic Colorectal Cancer
www.newswise.com/articles/may...
#metastaticcolorectalcancer #clinicalcancerresearch #mayoclinicresearch #Immunotherapy #immunotherapycancertreatments #digitalspatialprofiling

Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy - OncoDaily Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy / Ash Alizadeh, cancer, CAR T-cell therapy, Clinical Cancer Research, David Cordas dos

Comment from Kai Rejeski on our recent paper on Second Primary Malignancies following CAR T-cell therapy in #ClinicalCancerResearch @mskcancercenter.bsky.social #CARTcells #medsky oncodaily.com/insight/142707